市场竞争加剧，核心业务成本飙升，六国化工预亏超4亿

Core Viewpoint - Six Nations Chemical (600470.SH) is expected to report a significant loss in 2025, with both net profit and net profit after deducting non-recurring items projected to exceed a loss of 400 million yuan, marking the first time in six years that the company will transition from profit to loss [1][7]. Group 1: Financial Performance - The company anticipates a net profit loss of 480 million to 410 million yuan for 2025, compared to a profit of 25.18 million yuan in the previous year [2][8]. - The net profit after deducting non-recurring items is expected to be a loss of 485 million to 415 million yuan, down from a profit of 12.21 million yuan in the previous year [2][8]. - In the first three quarters of 2025, the company reported a revenue of 5.005 billion yuan, a year-on-year increase of 3.9%, but a net profit loss of 207.3 million yuan, a decline of 640% [9][3]. - The company's gross profit margin fell to 5.75%, the lowest in nearly a decade, due to rising costs and asset impairment losses [7][12]. Group 2: Industry Challenges - The fertilizer industry is facing overcapacity and rising raw material prices, which have significantly weakened the profitability of Six Nations Chemical [1][7]. - The company relies heavily on external procurement for key raw materials like phosphate rock and sulfuric acid, which puts it at a cost disadvantage compared to competitors with upstream resource control [2][8]. - The domestic fertilizer market is experiencing intensified competition and export restrictions, leading to a substantial decline in export sales [2][8]. Group 3: Strategic Initiatives - In January, the company announced a fundraising plan of up to 800 million yuan for a 280,000 tons/year battery-grade refined phosphoric acid project, aiming to diversify its business beyond basic fertilizers [6][13]. - The project has a construction period of 24 months, with potential risks if market demand does not meet expectations or if there are significant changes in technology [6][13]. - The fundraising application has been accepted by the Shanghai Stock Exchange, but its approval remains uncertain [6][13].